Editorial

Published on:January 2018
Indian Journal of Pharmacy Practice, 2017; 10(4):236
Editorial | doi:10.5530/ijopp.10.4.49


Editorial


Authors and affiliation (s):

Shobha Rani Hiremath

Principal and H.O.D. (Department of Pharmacy Practice), Al-Ameen College of Pharmacy, Bangalore, Karnataka, INDIA.

Abstract:

As we all know, Pharmacoeconomic research identifies, measures and compares the cost and consequences of treatment options. The consequences could be clinical, economical or humanistic. Humanistic outcomes represent the patient perspective and are important in life extending treatment options like in cancer chemotherapy as well as morbidity reducing therapy such as in arthritis. Among the four different methods of pharmacoeconomic evaluation, Cost Utility Analysis is the most appropriate method to measure the humanistic outcome which is generally expressed as the Quality-Adjusted Life Year (QALY) gained which measures health as a combination of the duration of life and the health-related quality of life. Read more.....




 

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmacy Practice (IJOPP) [ISSN-0974-8326] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJOPP uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2014 are being assigned DOIs for its permanent URLs